关于“细胞培养”的报告
-
-
艾媒咨询|2021年中国素质教育及细分行业市场现状及消费行为数据研究报告
随着未来基础教育人口的增多，及未来人才需求和人均可支配收入增加等因素，素质教育市场规模将逐步扩大，预计2022年行业复合增速增速达20.5%，市场规模达6313.2亿元。艾媒咨询分析师认为，素质教育行业市场空间广阔，未来行业赛道或将更加细分。比如科技、体育、艺术这些学科也会进一步分类，变得更加有针对性。以体育为例，橄榄球、射箭等这些细分赛道也会有众多企业进入，形成众多小而美的门类。各个门类发展的过程中，也会有领头羊逐渐出现。(《2021年中国素质教育和细分行业市场现状及消费行为数据研究报告》完整高清PDF版共81页，可点击文章底部报告下载按钮进行报告下载)
With the increase of basic education population, talent demand and per capita disposable income in the future, the market scale of quality education will gradually expand. It is expected that the compound growth rate of the industry will reach 20.5% and the market scale will reach 631.32 billion yuan in 2022. AI media consulting analysts believe that the quality education industry has a broad market space, and the industry track may be more subdivided in the future. For example, science and technology, sports and art will be further classified and become more targeted. Taking sports as an example, many enterprises will enter such subdivided tracks as football and archery, forming many small and beautiful categories. In the process of the development of various categories, leaders will gradually appear. (“iiMedia Report | Research Report on China's market status and consumption behavior data of quality education and industry segments in 2021”full version has 81 pages in total, please click the Browse HD Report button on the right side of the article to browse the report) -
艾媒咨询|2020年中国细胞生物产业和商业应用分析报告
本报告研究涉及企业/品牌/案例：华夏源、复星医药。
中国细胞生物产业类型呈现多样化趋势，细胞生物临床研究不断深化，伴随生态合作的拓展将进一步加速细胞生物产业生态圈的形成，生态圈的完善将在很大限度上推动产业快速发展。数据显示，中国细胞治疗企业融资金额不断增加，从2014年的0.2亿元增长至2019年的28.9亿元。其中，2018年中国细胞治疗企业融资额同比增长706.8%，呈现迅猛发展态势。未来中国细胞生物产业的发展将充满机遇，同时也有挑战并存。后续产业的发展，将在5G、人工智能等新技术应用下加速升级。面临多端变化的市场格局，企业也应积极开展生态合作以及更为密切关注市场需求动向，将疗法和新一代医疗创新技术深度融合，实现市场产品多元化与差异化，并推出独特性的精准治疗，从而最大限度地释放产业价值。
The types of cell biological industry in China show a trend of diversification, and the deepening of cell biological clinical research will further accelerate the formation of the cell biological industry ecosystem with the expansion of ecological cooperation, and the improvement of the ecosystem will promote the rapid development of the industry to a large extent. Data show that the financing amount of Chinese cell therapy enterprises keeps increasing, from 20 million yuan in 2014 to 2.89 billion yuan in 2019. Among them, in 2018, the financing amount of Chinese cell therapy enterprises increased by 706.8% year on year, showing a rapid development trend. In the future, the development of China's cell biology industry will be full of opportunities and challenges. The development of subsequent industries will be accelerated with the application of new technologies such as 5G and ARTIFICIAL intelligence. In the face of the changing market pattern, enterprises should also actively carry out ecological cooperation and pay close attention to the trend of market demand, deeply integrate therapy and new-generation medical innovation technology, realize the diversification and differentiation of market products, and launch unique precision therapy, so as to maximize the release of industrial value. -
